MicroRNA as Markers in Testicular Cancer
MicroRNA-371 as Markers for Disease Activity and as a Tool to Monitor the Effect of Chemotherapy and Early Detection of Recurrence in Patients With Testicular Germ Cell Tumours
Haukeland University Hospital
350 participants
Dec 31, 2016
OBSERVATIONAL
Conditions
Summary
The main objective of this study is establish the performance of miR371 in management of testicular cancer
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Blood collection. Blood samples will be collected at diagnosis, during surveillance, during treatment and every 3-6 months
Locations(6)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04914026